This dual benefit, enhanced fat burning through glucagon plus improved nutrient partitioning through GIP, creates a metabolic environment that is theoretically more favorable for preserving muscle during weight loss than single-receptor medications
In contrast, tesofensine-induced hypophagia was not affected by RX821002 (0.3 mg/kg, 2 adrenoceptor antagonist), haloperidol (0.03 mg/kg, D 2 receptor antagonist), NGB2904 (0.1 mg/kg, D 3 receptor antagonist), or ritanserin (0.03 mg/kg, 5-HT 2A/C receptor antagonist)
And the evidence shows the weight goes back on when people come off the drug, with people regaining around two-thirds of their lost weight within two years
Drugs with large secondary patent estates built on CIP filings made several years after the original compositions of matter filings are particularly exposed